Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0703_j.cell.2020.06.030

Repurposed integrin inhibitor for cardiac wound healing

Aug 28, 2020 | 12:14 AM GMT

DISEASE CATEGORY: Cardiovascular

INDICATION: Myocardial

Read the full 162 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE